Guégan Sarah, Garcia-Hermoso Dea, Sitbon Karine, Ahmed Sarah, Moguelet Philippe, Dromer Françoise, Lortholary Olivier
Assistance Publique-Hôpitaux de Paris, Service de Dermatologie, Hôpital Tenon; Université Pierre et Marie Curie-Paris VI; Institut National de la Santé et de la Recherche Médicale Unité 938, Saint Antoine Research Center.
Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques; Centre National de la Recherche Scientifique Unité de Recherche Associée 3012, Paris, France.
Open Forum Infect Dis. 2016 Jun 25;3(2):ofw106. doi: 10.1093/ofid/ofw106. eCollection 2016 Apr.
Background. Coelomycetes are rarely but increasingly reported in association with human infections involving mostly skin and subcutaneous tissues, both in immunocompetent and immunocompromised patients. Coelomycetes constitute a heterogeneous group of filamentous fungi with distinct morphological characteristics in culture, namely an ability to produce asexual spores within fruit bodies. Methods. We included all cases of proven primary cutaneous and/or subcutaneous infections due to coelomycetes received for identification at the French National Reference Center for Invasive Mycoses and Antifungals between 2005 and 2014. Eumycetoma, chromoblastomycosis, and disseminated infections were excluded. Results. Eighteen cases were analyzed. The median age was 60.5 years. In all cases, patients originated from tropical or subtropical areas. An underlying immunodepression was present in 89% of cases. Cutaneous and/or subcutaneous lesions, mainly nodules, abscesses, or infiltrated plaques, were observed in distal body areas. Isolates of different genera of coelomycetes were identified: Medicopsis (6), Paraconiothyrium (3), Gloniopsis (3), Diaporthe (3), Peyronellaea (2), Lasiodiplodia (1). Lesion treatment consisted of complete (10) or partial (2) surgical excision and/or the use of systemic antifungal therapy, namely voriconazole (5) and posaconazole (4). Literature review yielded 48 additional cases of cutaneous and/or subcutaneous infections due to coelomycetes. Conclusions. Infectious diseases physicians should suspect coelomycetes when observing cutaneous and/or subcutaneous infections in immunocompromised hosts from tropical areas; a sequence-based approach is crucial for strains identification but must be supported by consistent phenotypic features; surgical treatment should be favored for solitary, well limited lesions; new triazoles may be used in case of extensive lesions, especially in immunocompromised patients.
背景。腔孢纲真菌与人类感染相关的报道较少,但呈上升趋势,感染主要累及免疫功能正常和免疫功能低下患者的皮肤和皮下组织。腔孢纲真菌是一类异质性丝状真菌,在培养中有独特的形态特征,即在子实体内产生无性孢子的能力。方法。我们纳入了2005年至2014年间在法国国家侵袭性真菌病和抗真菌药物参考中心接受鉴定的所有经证实的由腔孢纲真菌引起的原发性皮肤和/或皮下感染病例。排除了真菌瘤、着色芽生菌病和播散性感染。结果。分析了18例病例。中位年龄为60.5岁。所有病例中,患者均来自热带或亚热带地区。89%的病例存在潜在的免疫抑制。在身体远端部位观察到皮肤和/或皮下病变,主要为结节、脓肿或浸润性斑块。鉴定出不同属的腔孢纲真菌分离株:拟茎点霉属(6株)、拟锥毛壳属(3株)、格孢腔菌属(3株)、间座壳属(3株)、茎点霉属(2株)、炭角菌属(1株)。病变治疗包括完整(10例)或部分(2例)手术切除和/或使用全身性抗真菌治疗,即伏立康唑(5例)和泊沙康唑(4例)。文献综述又发现了48例由腔孢纲真菌引起的皮肤和/或皮下感染病例。结论。感染病医生在观察来自热带地区的免疫功能低下宿主的皮肤和/或皮下感染时应怀疑腔孢纲真菌;基于序列的方法对于菌株鉴定至关重要,但必须有一致的表型特征支持;对于孤立、界限清楚的病变应首选手术治疗;对于广泛病变,尤其是免疫功能低下患者,可使用新型三唑类药物。